Skip to main content
Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
97.74
+2.02 (2.12%)
At close: Apr 28, 2026, 4:00 PM EDT
97.00
-0.74 (-0.76%)
After-hours: Apr 28, 2026, 4:26 PM EDT

Incyte Revenue

Incyte had revenue of $1.27B in the quarter ending March 31, 2026, with 20.87% growth. This brings the company's revenue in the last twelve months to $5.36B, up 21.48% year-over-year. In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth.

Revenue (ttm)
$5.36B
Revenue Growth
+21.48%
P/S Ratio
3.51
Revenue / Employee
$1,885,028
Employees
2,844
Market Cap
19.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.14B900.03M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
Genmab 3.72B
BioNTech SE 3.37B
Royalty Pharma 2.38B
Moderna 1.94B
Ascendis Pharma 845.52M
Insmed 606.42M
BridgeBio Pharma 502.08M
Revenue Rankings

INCY News

More News